Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Lindsay Bergan"'
Autor:
Michèl Schummer, Jason Thorpe, Maria D Giraldez, Lindsay Bergan, Muneesh Tewari, Nicole Urban
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147561 (2016)
Externí odkaz:
https://doaj.org/article/576c216d08514764b857d5be3679c9c7
Autor:
Michèl Schummer, Jason Thorpe, Maria D Giraldez, Lindsay Bergan, Muneesh Tewari, Nicole Urban
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0142911 (2015)
IntroductionBreast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in females worldwide. Death rates have been declining, largely as a result of early detection through mammography and improved treatment, but mamm
Externí odkaz:
https://doaj.org/article/805a8f8a693c4ff9a49c2ca854acb9ce
Autor:
Wei Zhao, Martin W. McIntosh, Matthew Fitzgibbon, Nigel Clegg, Gordon B. Mills, David A. Crispin, Lindsay Bergan
RNA-seq and mass-spectrometry proteomics combined with growing data repositories have greatly increased the capacity to identify candidate proteins or protein sequence variants that share properties of ideal therapy targets, which include being abund
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6901e85913bfda37ce74935d5736de42
https://europepmc.org/articles/PMC5839124/
https://europepmc.org/articles/PMC5839124/
Autor:
Nicole Urban, Jason D. Thorpe, Michèl Schummer, María Dolores Giráldez, Muneesh Tewari, Lindsay Bergan
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147561 (2016)
PLoS ONE
PLoS ONE
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in females worldwide. Death rates have been declining, largely as a result of early detection through mammography and improved treatment, but mammographic scr
Autor:
Mark D. Thornquist, Lieling Wu, Nicole Urban, Jason D. Thorpe, Garnet L. Anderson, Kathy O'Briant, Matt J. Barnett, Martin W. McIntosh, Nathalie Scholler, Nam Hee Kim, Charles W. Drescher, Gary E. Goodman, Lindsay Bergan
Publikováno v:
JNCI: Journal of the National Cancer Institute. 102:26-38
CA125, human epididymis protein 4 (HE4), mesothelin, B7-H4, decoy receptor 3 (DcR3), and spondin-2 have been identified as potential ovarian cancer biomarkers. Except for CA125, their behavior in the prediagnostic period has not been evaluated.Immuno
Autor:
Kimberly A. Lowe, Nicole Urban, Nathalie Scholler, M. Robyn Andersen, Lindsay Bergan, Barbara A. Goff, Pamela J. Paley, Charles W. Dresher
Publikováno v:
Cancer. 113:484-489
Ovarian cancer is the second most common gynecologic malignancy in the U.S. Greater than 70% of women with ovarian cancer are diagnosed with advanced stage disease, in which the cure rates are only 20% to 30%, making it also the most deadly cancer.1
Autor:
Martin W. McIntosh, Jason D. Thorpe, Robin M. Forrest, Nicole Urban, Patricia Hartge, Kathy O'Briant, Archana V. Kampani, Christine D. Berg, Daniel W. Cramer, Nathalie Scholler, Charles W. Drescher, Garnet L. Anderson, Lindsay Bergan
Publikováno v:
Journal of the National Cancer Institute. 103(21)
In screening for epithelial ovarian cancer, unnecessary surgery can be reduced by limiting use of transvaginal ultrasound (TVU) to women with increasing CA125 serum levels. Replacing or augmenting TVU with measurement of a serum marker specific for m
Autor:
Nicole Urban, Barbara A. Goff, Pamela J. Paley, Lindsay Bergan, Kimberly A. Lowe, Nathalie Scholler, Charles W. Drescher, M. Robyn Andersen
Background. Prior studies suggest that combining the Symptom Index (SI) with a serum HE4 test or a CA125 test may improve prediction of ovarian cancer. However, these three tests have not been evaluated in combination. Methods. A prospective case–c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::955b7551fc17f7e5dca5e4266defc053
https://europepmc.org/articles/PMC2822097/
https://europepmc.org/articles/PMC2822097/
Autor:
Nicole Urban, Martin W. McIntosh, Garnet L. Anderson, Charles W. Drescher, Lindsay Bergan, Jason D. Thorpe, M. Robyn Andersen, Kimberly A. Lowe, Nathalie Scholler, Erin Wallace, Pamela J. Paley, Chirag A. Shah
Objective: To evaluate the effect of ovarian cancer risk on the performance of the serum biomarkers mesothelin, human epididymis protein 4 (HE4), and CA125. Methods: We measured mesothelin, HE4, and CA125 levels from women with invasive ovarian cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4910cad1c186d2e8f11c0613a20263e2
https://europepmc.org/articles/PMC2714056/
https://europepmc.org/articles/PMC2714056/
Autor:
M. Robyn Andersen, Jason D. Thorpe, Pamela J. Paley, Nicole Urban, Kimberly A. Lowe, Nathalie Scholler, Charles W. Drescher, Erin Wallace, Chirag A. Shah, Garnet L. Anderson, Martin W. McIntosh, Lindsay Bergan
Publikováno v:
Cancer epidemiology, biomarkersprevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(9)
Objective: To evaluate if serum levels of candidate ovarian cancer biomarkers vary with individual characteristics of healthy women who are likely candidates for an ovarian cancer screening program. Methods: We analyzed serum CA125, mesothelin, and H